I wanted to share some of my thoughts on today's Supreme Court decision on affirmative action:

Plasmids with #AMR genes can be transferred between different bacteria & therefore contribute to new drug-resistant microbes. In this guide, learn how nanopore sequencing can characterise full-length plasmids to better study & understand AMR. Read here: bit.ly/45zrCRT

We get ever closer to enabling anyone to sequence anything anywhere. Sometimes it’s a Nanopore breakthrough- sometimes the tech industry thrusts this vision forward. Enabling MinIONs on iPads and P2solos on macs removes a massive barrier to adoption! Can’t wait to test M3!

Happy #WorldScienceDay! To celebrate we're offering 5 free in-person tickets to NCM Houston (6th Dec). To be with in a chance of winning: like, retweet and comment why you would like to join us in Houston by 11:59 (PT) Tuesday #nanoporeconf 1/3

The long-reads permit direct haplotype phasing and strengthen star-allele calling of the GIAB samples compared to the Get-RM reference. We show that the ability to call star-alleles based on Oxford Nanopore data is only limited by the tools available. More info in the paper! (2/2)

Our US based NCM meeting is approaching, now in a new venue, sadly it’s unlikely i will be there this year. But in the traditions of ONT i will post a few teasers in the run up to the meeting on the understanding this is WIP. 1/n

Today, Oxford Nanopore & MATRIX announce a collaboration to explore the clinical value of #nanopore sequencing in precision cancer medicine. The initial focus will be on DNA methylation-based classification of CNS tumours, CNVs, & single-cell heterogeneity. bit.ly/47q3bXQ

Congrats on the publication! This research won the 'highly commended' poster award during this year's London Calling. Make sure you check out his publication below as well as his poster and talk from London Calling here: nanoporetech.com/resource-centr… #nanoporeconf.

EPI2ME: data analysis for all levels of expertise. Run preconfigured workflows from the EPI2ME application or the command line. Get comprehensive reports and rapid insights to make the most of your sequencing runs. Learn more: bit.ly/46BNZpV #AnythingAnyoneAnywhere

3 days to go! If you're unable to join us for NCM Houston, don't worry you can attend online! Check out what we've got in store and make sure register to attend online, free-of-charge. Register here: bit.ly/46MQndf

2024 #internships & #placements are now live! At Oxford Nanopore, we have internships for #students & #graduates who are interested in pursuing a #career in #science. Interested in joining the team? Learn more: bit.ly/3N4AvvG #stem #studentplacements

Onward antpruitt.com/blog/onward 🌳

“I can’t help but wonder how many new explanations we’re going to have for some of these complex diseases we don’t understand right now” — Winston Timp on the future impact of genomics on medicine. What you’re missing matters. #WYMM

Are you looking for an internship in an innovative, technology company? Find out from Jane, Development Scientist, what it's like to look after the design, software & hardware of our devices as well as the day-to-day life at Oxford Nanopore. Learn more: bit.ly/48iFCAC

7 years ago at the Nanopore Community Meeting in New York, to running a cutting-edge lab today in Bangkok! Incredible to see the impact you’ve had on the Oxford Nanopore community building genomics capacity and expertise across the region Tip 🧬

Join hosts Karen Miga & Adam Phillippy as they bring together experts from around the world to share their insights into telomere-to-telomere (#T2T) assembly, and highlight the advantages, breakthroughs and obstacles of ultra-long sequencing. Register: bit.ly/3PFTa2f

Registration open for the T2T Oxford Nanopore Ultralong workshop online next week organized by Karen Miga and Adam Phillippy. Open to all to hear the latest advances in ultralong preps and applications! ucsc-seqtech-events.online/?utm_campaign=…

Cancer is a multifactorial disease that cannot be fully explained via SNVs detected using short reads. This white paper outlines how #nanopore tech can analyse the role of SNVs, SVs, & methylation to provide the most comprehensive view of cancer: bit.ly/3ITvpQA #AACR24

Paired tumour-normal whole-genome sequencing enables a deeper understanding of genomic & epigenomic variability in cancer. Here we present an end-to-end workflow to detect somatic variation between tumour-normal paired research samples. Read here: bit.ly/4at8jfn #AACR24

Proud to partner with UK Government, Genomics England, UK Biobank, & NHS England to drive genomics-based healthcare in the UK! This initiative supports breakthroughs in patient care, biomedical research, and pandemic preparedness. Read more here: bit.ly/4fsojRa